Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Peanut allergy is known to cause severe anaphylactic reactions.The goal of this proposal is
to produce a new treatment that would benefit young subjects who have recently been diagnosed
with peanut allergy by lowering the risk of anaphylactic reactions (desensitization), and
changing the peanut-specific immune response in subjects who have peanut allergy (tolerance).